Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
SPRY
$5.65
-7.38%
SPRY · ARS Pharmaceuticals, Inc.
$5.65
-0.45 (-7.38%)
At close · Aug 14
Market Cap
$561.88M
Shares
99.45M
All earnings calls
Earnings call · FY2026 Q2
ARS Pharmaceuticals 2Q 2026 Financial Results Conference Call
ARS Pharmaceuticals 2Q 2026 Financial Results Conference Call
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$33.66M
+114.2% YoY
Diluted EPS
-$0.63
Net income
-$62.34M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
Company presentation
Slides
10 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Aug 13, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 13, 2026 · complete as-filed document